Potentially AI (LON: AGI) shares rebounded 46% to 8.25p after a small decline in the previous week. Potentially AI started trading on 13 July after the AI business reversed into Tiger Alpha. There was a ten-for-one share consolidation and £4.9m was raised at 5p/share. There are plans to launch three products in the second half of 2026.
Healthy food and snacks supplier Tooru (LON: TOO) says that the OAF range is increasing sales each week, while significant growth is expected from Pulsin thanks to launches in additional retailers. The share price increased 36% to 0.17p.
Wound healing technology developer AOTI Inc (LON: AOTI) says the Centers for Medicare & Medicaid Services (CMS) has issued a proposed Local Coverage Determination (LCD). This covers the whole of the US and indicates that the AOTI topical oxygen therapy can be used to treat diabetic foot ulcers that have failed to heal with four consecutive weeks of optimized diabetic foot ulcer care. This decision has a 45-day public comment period, but it would significantly increase the addressable market, which in the medium term could be around $400m annually. Broader coverage would further increase the market. A trading statement will be published on 27 July. The share price jumped 32.6% to 87.5p.
Semiconductor wafers manufacturer IQE (LON: IQE) says first half trading beat expectations and interim revenues were at least £64m. Cash was £41.6m at the end of June 2026. Demand for Indium Phosphide (InP) product demand is accelerating with additional growth in aerospace, defence, wireless and 3D sensing. Full year revenues are expected to grow b30% and EBITDA should be in the low teens. The share price gained 32.6% to 48.85p.
Construction staff provider Hercules (LON: HERC) non-executive director Martin Tedham bought 110,000 shares at 31p each, 50,000 shares at 32p each and 285,160 shares at 34.75p each. Chief executive Brusk Korkmaz acquired 100,000 shares at 39.75p each. The share price improved 31.1% to 40p.
Sunrise Resources (LON: SRES) has established the Lake copper silver gold project in Nevada. Copper and silver mineralisation occurs at surface. There is historical drilling that intersected mineralisation. The share price rose 29.6% to 0.0175p.
PACSCo Ltd (LON: PACS) is awaiting one further approval of the sale of its businesses in Mozambique. Management is seeking reverse takeover candidates in any sector. They have to have positive cash generation and growth potential that would be attractive to institutional investors. A strong management team is also required. The share price recovered 28.2% to 0.45p.
FALLERS
Scancell (LON: SCLP) is merging with Nasdaq listed Neuphoria Therapeutics in an all-share deal and the combined entity will be quoted on AIM and Nasdaq. Scancell shareholders will own 85.5% of the company. Neuphoria has £7.5m in cash and a private placement will raise a further £29.2m. A UK placing will raise £9m at 9p/share, which is not dependent on the merger going ahead, and a retail offer could raise up to £2.3m. The pro forma cash balance after the merger would be £59.2m. The cash will last into 2028 and finance the global phase 3 trial for iSCIB1+ active immunotherapy in advanced melanoma. The phase 2 SCOPE study should be published within one year. The share price slipped 29.1% to 9.4p.
Celsius Resources (LON: CLA) says Kiri Industries, which owns Equinaire, has reiterated that it acquired the loan with Makilala Mining Company because it wants to secure an offtake agreement for copper ore/concentrate produced at the MCB project in the Philippines. Equinaire issued a notice of event default and notice of commencement of foreclosure proceedings, and this would enforce the security relating to Celsius Resources’ 40% interest in Makilala Mining Company. A notice of disposition seeks to initiate a public auction of the 40% interest. Celsius Resources refutes the default and the attempt to sell its stake. The share price declined 28.6% to 0.25p.